GeneDx Holdings (WGS) Net Margin (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Net Margin of 61.92% for Q1 2026, down 5443.0% year-over-year from 1.16% in Q1 2025, and down 324.09% quarter-over-quarter from 14.6% in Q4 2025.
GeneDx Holdings (WGS) Net Margin (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Net Margin for 7 consecutive years, with 61.92% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin fell 5443.0% year-over-year to 61.92%; the TTM figure through Mar 2026 stood at 17.57% (down 589.0% YoY), while the FY2025 annual figure was 4.92%, up 1220.0% from the prior year.
- Net Margin eased to 61.92% in Q1 2026 per WGS's latest filing, from 14.6% in the prior quarter.
- Across five years, Net Margin topped out at 10.53% in Q2 2025 and bottomed at 503.21% in Q4 2022.
- Historically, Net Margin has averaged 88.02% across 5 years, with a median of 44.86% in 2023.
- Annual changes were most pronounced in 2022 — Net Margin plunged 43369 bps — and 2023, when it surged 45835 bps.
- GeneDx Holdings' Net Margin stood at 503.21% in 2022, then jumped by 91 bps to 44.86% in 2023, then jumped by 113 bps to 5.71% in 2024, then plunged by 356 bps to 14.6% in 2025, then slumped by 324 bps to 61.92% in 2026.
- Business Quant data shows WGS's Net Margin at 61.92% in Q1 2026, 14.6% in Q4 2025, and 6.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 13.89% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 27.82% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.52% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.22% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 22.67% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.65% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -15.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.50% |
| Mar 31, 2026 | -61.92% |
| Dec 31, 2025 | -14.60% |
| Sep 30, 2025 | -6.50% |
| Jun 30, 2025 | 10.53% |
| Mar 31, 2025 | -7.49% |
| Dec 31, 2024 | 5.71% |
| Sep 30, 2024 | -10.81% |
| Jun 30, 2024 | -41.36% |
| Mar 31, 2024 | -32.42% |
| Dec 31, 2023 | -44.86% |
| Sep 30, 2023 | -79.33% |
| Jun 30, 2023 | -95.92% |
| Mar 31, 2023 | -141.38% |
| Dec 31, 2022 | -503.21% |
| Sep 30, 2022 | -93.21% |
| Jun 30, 2022 | -237.06% |
| Mar 31, 2022 | -142.56% |
| Dec 31, 2021 | -69.52% |
| Sep 30, 2021 | 75.80% |